Skip to main content Skip to section navigation Skip to footer

Investors & Media

News & Events

Recent NewsView All News

Jul 24, 2025 8:00 am EDT

Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel®) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease

Jul 14, 2025 8:00 am EDT

Atara Biotherapeutics Provides Regulatory and Business Updates on Tabelecleucel (Tab-cel®)

Recent Events View All Events

Jun 10, 2025 9:00 am PDT

Annual Meeting of Stockholders

Webcast

Audio

View All Events

Latest Presentation View All Presentations

Investor Presentation thumbnail

Nov 12, 2024

Investor Presentation

H.C. Wainwright 26th Annual Global Investment Conference thumbnail

Sep 9, 2024

H.C. Wainwright 26th Annual Global Investment Conference

View All Presentations

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings